-
Mashup Score: 0
Removing race from the CKD-EPI equation will calculate a lower eGFR for Black patients and exclude more patients from receiving anticancer therapy, which could lead to undertreatment of Black patients with cancer and adversely affect their outcomes.
Source: The Lancet OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Optimizing Regorafenib Dosing and Patient Management in Colorectal Cancer in Latin America: Perspectives from Argentina - 3 year(s) ago
The Oncologist is committed to helping physicians excel in the constantly changing fields of oncology and hematology through the publication of timely reviews, original studies, and commentaries on important developments.
Source: The OncologistCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
COMMENTARY: Optimizing Regorafenib Dosing and Patient Management in Colorectal Cancer in Latin America: Perspectives from Argentina #Regorafenib #MetastaticColorectalCancer #CRC #Dosing #HandFootSkinReaction https://t.co/ezoW2g4y1C https://t.co/m7buOHfRgf
-
-
Mashup Score: 8
VOLUNTARY INFORMED CONSENT This research study was created by metastatic breast cancer (MBC) patient advocates and medical oncologists who are members of the Patient-Centered Dosing Initiative. The study’s dual objective is to expand current knowledge of MBC patients’ treatment-related side effects and provide greater understanding regarding the impact…
Source: Google DocsCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @itsnot_pink: Med oncs treating MBC pts in US: Take survey on #dosing! https://t.co/BvwZZYKXPk Quick, easy & IMPORTANT! PI: @maryam_l…
-
RT @itsnot_pink: Med oncs treating MBC pts in US: Take survey on #dosing! https://t.co/BvwZZYKXPk Quick, easy & IMPORTANT! PI: @maryam_l…
-
-
Mashup Score: 5
VOLUNTARY INFORMED CONSENT This research study was created by metastatic breast cancer (MBC) patient advocates and medical oncologists who are members of the Patient-Centered Dosing Initiative. The study’s dual objective is to expand current knowledge of MBC patients’ treatment-related side effects and provide greater understanding regarding the impact…
Source: Google DocsCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @itsnot_pink: Med oncs treating MBC pts in US: Take this survey about #dosing! https://t.co/BvwZZYKXPk Quick, easy & important! PI: @…
-
Online First: Effect of removing #race from glomerular filtration rate-estimating equations on #anticancer #drug #dosing and eligibility: a retrospective analysis of National Cancer Institute phase 1 clinical trial participants https://t.co/YTvNwQsOE7